Redmile Group, LLC
- SEC CIK
- 0001425738
- Latest filing
- Aug 14, 2026
Holdings in Q2 2023
Holdings as of Jun 30, 2023, filed Aug 14, 2023. Long positions only; changes compare share counts with Q1 2023.
- Positions
- 72
- −4 vs. Q1 2023
- Portfolio value
- $2.61B
- +$300.8M (+13.1%) vs. Q1 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| IMGNImmunoGen, Inc. | COM | 17,730,417 | $334.6M | 12.8% | +9,684,200+120.4% | Added | History |
| KRYSKrystal Biotech, Inc. | COM | 2,566,661 | $301.3M | 11.6% | +653,381+34.1% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 19,566,961 | $245.8M | 9.4% | +1,220,100+6.7% | Added | History |
| REPLReplimune Group, Inc. | COM | 4,420,533 | $102.6M | 3.9% | +608,545+16.0% | Added | History |
| AKROAkero Therapeutics, Inc. | COM | 1,811,672 | $84.6M | 3.2% | −232,717−11.4% | Reduced | History |
| AUGXAugmedix, Inc. | COM | 15,630,327 | $75.2M | 2.9% | +1,250,000+8.7% | Added | History |
| DCPHDeciphera Pharmaceuticals, Inc. | COM | 4,878,566 | $68.7M | 2.6% | −703,539−12.6% | Reduced | History |
| FATEFate Therapeutics Inc | COM | 13,124,427 | $62.5M | 2.4% | +167,205+1.3% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 1,696,004 | $57.5M | 2.2% | −183,735−9.8% | Reduced | History |
| LIVNLivaNova PLC | SHS | 1,100,492 | $56.6M | 2.2% | −85,926−7.2% | Reduced | History |
| CTLTCatalent, Inc. | COM | 1,162,166 | $50.4M | 1.9% | +551,862+90.4% | Added | History |
| ZYMEZymeworks Inc. | COM | 5,661,230 | $48.9M | 1.9% | −406,688−6.7% | Reduced | History |
| PLRXPliant Therapeutics, Inc. | COM | 2,678,099 | $48.5M | 1.9% | −247,549−8.5% | Reduced | History |
| PENPenumbra Inc | COM | 138,970 | $47.8M | 1.8% | −49,022−26.1% | Reduced | History |
| BEAMBeam Therapeutics Inc. | COM | 1,485,199 | $47.4M | 1.8% | −126,895−7.9% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 1,120,476 | $43.1M | 1.7% | −205,356−15.5% | Reduced | History |
| KYMRKymera Therapeutics, Inc. | COM | 1,868,507 | $43.0M | 1.6% | −542,262−22.5% | Reduced | History |
| BMRNBiomarin Pharmaceutical Inc | COM | 489,208 | $42.4M | 1.6% | +154,038+46.0% | Added | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 341,882 | $42.4M | 1.6% | +6,723+2.0% | Added | History |
| STOKStoke Therapeutics, Inc. | COM | 3,955,188 | $42.0M | 1.6% | −190,208−4.6% | Reduced | History |
| RGNXREGENXBIO Inc. | COM | 2,026,576 | $40.5M | 1.6% | +385,851+23.5% | Added | History |
| DXCMDexcom Inc | COM | 289,161 | $37.2M | 1.4% | −46,887−14.0% | Reduced | History |
| IMVTImmunovant, Inc. | COM | 1,921,152 | $36.4M | 1.4% | +604,121+45.9% | Added | History |
| ELVElevance Health, Inc. | Stock | 78,313 | $34.8M | 1.3% | +11,915+17.9% | Added | History |
| SRRKScholar Rock Holding Corp | COM | 4,403,840 | $33.2M | 1.3% | +1,279,614+41.0% | Added | History |
| VTYXVentyx Biosciences, Inc. | COM | 940,493 | $30.8M | 1.2% | +124,719+15.3% | Added | History |
| ADCTADC Therapeutics SA | SHS | 14,049,935 | $30.2M | 1.2% | +484,686+3.6% | Added | History |
| NRIXNurix Therapeutics, Inc. | COM | 2,857,309 | $28.5M | 1.1% | +107,925+3.9% | Added | History |
| IGMSIGM Biosciences, Inc. | COM | 2,971,542 | $27.4M | 1.1% | −362,813−10.9% | Reduced | History |
| SYKStryker Corp | Stock | 85,899 | $26.2M | 1.0% | −50,565−37.1% | Reduced | History |
| RPTXRepare Therapeutics Inc. | COM | 2,428,335 | $25.7M | 1.0% | −104,715−4.1% | Reduced | History |
| COGTCogent Biosciences, Inc. | COM | 2,053,333 | $24.3M | 0.9% | +2,053,333 | New | History |
| CRLCharles River Laboratories International, Inc. | COM | 114,351 | $24.0M | 0.9% | −977−0.8% | Reduced | History |
| ZBHZimmer Biomet Holdings, Inc. | Stock | 151,372 | $22.0M | 0.8% | +151,372 | New | History |
| IQVIQVIA Holdings Inc. | Stock | 94,409 | $21.2M | 0.8% | +22,752+31.8% | Added | History |
| BSXBoston Scientific Corp | Stock | 391,178 | $21.2M | 0.8% | +219,398+127.7% | Added | History |
| HUMHumana Inc | Stock | 46,310 | $20.7M | 0.8% | −5,769−11.1% | Reduced | History |
| VERVVerve Therapeutics, Inc. | COM | 1,061,960 | $19.9M | 0.8% | −58,719−5.2% | Reduced | History |
| TRDAEntrada Therapeutics, Inc. | COM | 1,311,572 | $19.9M | 0.8% | −520,036−28.4% | Reduced | History |
| PRMEPrime Medicine, Inc. | COM | 1,324,350 | $19.4M | 0.7% | −668,493−33.5% | Reduced | History |
| CABACabaletta Bio, Inc. | COM | 1,370,299 | $17.7M | 0.7% | +1,096,047+399.6% | Added | History |
| STTKShattuck Labs, Inc. | COM | 5,619,914 | $17.5M | 0.7% | 00.0% | Unchanged | History |
| ETNB89bio, Inc. | COM | 761,955 | $14.4M | 0.6% | −138,045−15.3% | Reduced | History |
| GRTSGritstone bio, Inc. | COM | 6,860,226 | $13.4M | 0.5% | −66,700−1.0% | Reduced | History |
| ANNXAnnexon, Inc. | COM | 3,503,190 | $12.3M | 0.5% | 00.0% | Unchanged | History |
| ABSIAbsci Corp | COM | 8,031,094 | $12.2M | 0.5% | 00.0% | Unchanged | History |
| ALLKAllakos Inc. | COM | 2,283,594 | $9.96M | 0.4% | −2,583−0.1% | Reduced | History |
| STXSStereotaxis, Inc. | COM NEW | 6,373,898 | $9.75M | 0.4% | +4,886,403+328.5% | Added | History |
| ATRAAtara Biotherapeutics, Inc. | COM | 6,048,123 | $9.74M | 0.4% | +436,067+7.8% | Added | History |
| ALXOAlx Oncology Holdings Inc | COM | 1,283,289 | $9.64M | 0.4% | +696,312+118.6% | Added | History |
| MDVLMedAvail Holdings, Inc. | COM | 34,604,516 | $8.48M | 0.3% | 00.0% | Unchanged | History |
| RAPTRAPT Therapeutics, Inc. | COM | 431,919 | $8.08M | 0.3% | −256,213−37.2% | Reduced | History |
| SLRNACELYRIN, Inc. | COM | 364,493 | $7.62M | 0.3% | +364,493 | New | History |
| STVNStevanato Group S.p.A. | ORD SHS | 218,169 | $7.06M | 0.3% | −683,763−75.8% | Reduced | History |
| KLRSKalaris Therapeutics, Inc. | COM | 1,907,969 | $6.49M | 0.2% | 00.0% | Unchanged | History |
| EVHEvolent Health, Inc. | CL A | 213,432 | $6.47M | 0.2% | +213,432 | New | History |
| MRSNMersana Therapeutics, Inc. | COM | 1,698,626 | $5.59M | 0.2% | +1,698,626 | New | History |
| GRFSGrifols SA | SP ADR REP B NVT | 600,684 | $5.50M | 0.2% | −120,100−16.7% | Reduced | History |
| NUVBNuvation Bio Inc. | COM CL A | 3,031,009 | $5.46M | 0.2% | 00.0% | Unchanged | History |
| SLGCSomaLogic, Inc. | CLASS A COM | 1,870,839 | $4.32M | 0.2% | 00.0% | Unchanged | History |
| LVTXLAVA Therapeutics NV | SHS | 2,074,372 | $4.21M | 0.2% | 00.0% | Unchanged | History |
| SNCEScience 37 Holdings, Inc. | COM | 19,808,234 | $4.21M | 0.2% | 00.0% | Unchanged | History |
| HOOKHOOKIPA Pharma Inc. | COM | 3,288,469 | $2.89M | 0.1% | +735,520+28.8% | Added | History |
| XERSXeris Biopharma Holdings, Inc. | COM | 1,046,587 | $2.74M | 0.1% | 00.0% | Unchanged | History |
| NVTAInvitae Corp | COM | 2,280,403 | $2.58M | 0.1% | 00.0% | Unchanged | History |
| NGNENeurogene Inc. | COM | 2,912,228 | $2.42M | 0.1% | +1,064,628+57.6% | Added | History |
| Achilles Therapeutics PLC00449L102 | SPONSORED ADS | 1,608,089 | $1.52M | 0.1% | 00.0% | Unchanged | – |
| IVVDInvivyd, Inc. | COM | 1,440,725 | $1.51M | 0.1% | 00.0% | Unchanged | History |
| TKNOAlpha Teknova, Inc. | COM | 308,852 | $824.6K | <0.1% | −64,392−17.3% | Reduced | History |
| SONXSonendo, Inc. | COM | 498,131 | $677.5K | <0.1% | 00.0% | Unchanged | History |
| ADAPYAdaptimmune Therapeutics PLC | SPONDS ADR | 715,607 | $661.9K | <0.1% | +715,607 | New | History |
| BCELAtreca, Inc. | CL A COM | 442,653 | $433.8K | <0.1% | 00.0% | Unchanged | History |
Sold out since Q1 2023 (10)
Positions held at the end of Q1 2023 that are gone from this filing.
| Security | Class | Shares in Q1 2023 | Value in Q1 2023 | % of portfolio in Q1 2023 | History |
|---|---|---|---|---|---|
| ISEEIVERIC bio, Inc. | COM | 4,205,206 | $102.3M | 4.4% | History |
| ARGXArgenx SE | SPONSORED ADR | 130,540 | $48.6M | 2.1% | History |
| OSHOak Street Health, Inc. | COM | 1,061,295 | $41.1M | 1.8% | History |
| SRPTSarepta Therapeutics, Inc. | COM | 231,595 | $31.9M | 1.4% | History |
| BMYBristol Myers Squibb Co | Stock | 449,442 | $31.2M | 1.4% | History |
| CNCCentene Corp | Stock | 277,351 | $17.5M | 0.8% | History |
| ILMNIllumina, Inc. | COM | 33,496 | $7.79M | 0.3% | History |
| TCRRTCR2 Therapeutics Inc. | COM | 658,336 | $987.5K | <0.1% | History |
| CTSOCytosorbents Corp | COM NEW | 181,639 | $612.1K | <0.1% | History |
| STLNStarling Oncology, Inc. | COM | 318,082 | $215.6K | <0.1% | History |